Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Medical University of South Carolina |
---|---|
Information provided by: | Medical University of South Carolina |
ClinicalTrials.gov Identifier: | NCT00330278 |
This is a randomized, double-blinded placebo controlled trial of cefazolin timing before cesarean section fo infection prophylaxis. Subjects are randomized to cefazolin either 30 minutes prior to skin incision or at time of cord-clamping. Primary outcome is infectious morbidity including wound infections and endometritis.
Condition | Intervention |
---|---|
Endometritis Wound Infection |
Drug: Cefazolin |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Randomized, Double-Blind, Placebo Controlled Trial of Cefazolin Given Either 30 Minutes Prior to Cesarean Section or at Cord Clamping |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Pregnant 24-43 weeks gestation > 18 years old Requiring cesarean section -
Exclusion Criteria:
Receiving antibiotics < 18 years old Allergy to cefazolin
-
United States, South Carolina | |
Medical University of South Carolina | |
Charleston, South Carolina, United States, 29425 |
Principal Investigator: | Scott A Sullivan, MD | Medical University of South Carolina |
Study ID Numbers: | HR # 11120 |
Study First Received: | May 25, 2006 |
Last Updated: | September 26, 2007 |
ClinicalTrials.gov Identifier: | NCT00330278 |
Health Authority: | United States: Food and Drug Administration |
Cesarean section Antibiotic prophylaxis Cefazolin |
Genital Diseases, Female Cefazolin Endometritis Wounds and Injuries |
Disorders of Environmental Origin Uterine Diseases Pelvic Inflammatory Disease Wound Infection |
Anti-Infective Agents Anti-Bacterial Agents Therapeutic Uses |
Infection Pharmacologic Actions Adnexal Diseases |